Excedrin Pm Triple Action Caplets And Excedrin Tension Headache Kit
NDC Package 0067-8147-01
Package Information
Excedrin Pm Triple Action Caplets And Excedrin Tension Headache (acetaminophen, aspirin (nsaid), caffeine, and diphenhydramine citrate) kits is •do not use more than directed•do not use in children under 12 years of age•adults and children 12 years of age and over: take 2 caplets at bedtime, with a full glass of water•do not take more than 2 caplets in 24 hours, unless directed by a doctor •do not use more than directed•adults and children 12 years and over; take 2 caplets every 6 hours; not more than 6 caplets in 24 hourschildren under 12 years: ask a doctor. This formulation utilizes a kit delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0067-8147 and is authorized under FDA application M013.
Identification & Billing
- RxCUI: 1593110 - acetaminophen 250 MG / aspirin 250 MG / diphenhydrAMINE citrate 38 MG Oral Tablet
- RxCUI: 1593110 - acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet
- RxCUI: 1593110 - APAP 250 MG / ASA 250 MG / Diphenhydramine Citrate 38 MG Oral Tablet
- RxCUI: 1593116 - Excedrin PM Triple Action (250 MG / 250 MG / 38 MG) Oral Tablet
- RxCUI: 1593116 - acetaminophen 250 MG / aspirin 250 MG / diphenhydramine citrate 38 MG Oral Tablet [Excedrin PM Triple Action]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0067 - Haleon Us Holdings Llc
- 0067-8147 - Excedrin Pm Triple Action Caplets And Excedrin Tension Headache
- 0067-8147-01 - 1 KIT in 1 PACKAGE, COMBINATION * 1 BOTTLE in 1 CARTON (0067-2056-24) / 24 TABLET, COATED in 1 BOTTLE * 1 BOTTLE in 1 CARTON (0067-8139-02) / 100 TABLET, FILM COATED in 1 BOTTLE
- 0067-8147 - Excedrin Pm Triple Action Caplets And Excedrin Tension Headache
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0067-8147-01 identifies a specific commercial package of 1 kit in 1 package, combination * 1 bottle in 1 carton (0067-2056-24) / 24 tablet, coated in 1 bottle * 1 bottle in 1 carton (0067-8139-02) / 100 tablet, film coated in 1 bottle of Excedrin Pm Triple Action Caplets And Excedrin Tension Headache, a human over the counter drug labeled by Haleon Us Holdings Llc. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on June 01, 2017. The current certification is valid through December 31, 2026.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00067814701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.